Andrea Reszegi
Overview
Explore the profile of Andrea Reszegi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baghy K, Ladanyi A, Reszegi A, Kovalszky I
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139365
Similarly to our healthy organs, the tumor tissue also constitutes an ecosystem. This implies that stromal cells acquire an altered phenotype in tandem with tumor cells, thereby promoting tumor survival....
2.
Petovari G, Toth G, Turiak L, L Kiss A, Paloczi K, Sebestyen A, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762298
Tumors are intricate ecosystems where cancer cells and non-malignant stromal cells, including cancer-associated fibroblasts (CAFs), engage in complex communication. In this study, we investigated the interaction between poorly (HLE) and...
3.
Vancza L, Karaszi K, Peterfia B, Turiak L, Dezso K, Sebestyen A, et al.
Front Oncol
. 2023 May;
13:1203745.
PMID: 37152016
[This corrects the article DOI: 10.3389/fonc.2022.819883.].
4.
Vancza L, Horvath A, Seungyeon L, Rokusz A, Dezso K, Reszegi A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046698
Purpose: Sparc/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1) has been found in a variety of malignant tumors and is associated with a poor prognosis. We aimed to explore the...
5.
Pesti A, Danics K, Glasz T, Varkonyi T, Barbai T, Reszegi A, et al.
Geroscience
. 2022 Dec;
45(2):1015-1031.
PMID: 36527584
The most severe alterations in Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) infection are seen in the lung. However, other organs also are affected....
6.
Reszegi A, Tatrai P, Regos E, Kovalszky I, Baghy K
Am J Physiol Cell Physiol
. 2022 Jun;
323(2):C289-C294.
PMID: 35704700
Syndecan-1 (SDC-1) is a heparan sulfate (HS)/chondroitin sulfate proteoglycan (PG) of the cell surface and the extracellular matrix (ECM), which regulates a broad spectrum of physiological and pathological processes such...
7.
Vancza L, Tatrai P, Reszegi A, Baghy K, Kovalszky I
Am J Physiol Cell Physiol
. 2022 Mar;
322(4):C688-C693.
PMID: 35235422
SPOCK1, 2, and 3 are considered matricellular proteoglycans without a structural role. Their functions are only partly elucidated. SPOCK1 was detected in the brain as a member of the neural...
8.
Spinelli F, Rosales P, Pluda S, Vitale D, Icardi A, Guarise C, et al.
IUBMB Life
. 2022 Feb;
74(10):927-942.
PMID: 35218610
Hyaluronan (HA) is a component of the extracellular matrix (ECM) it is the main non-sulfated glycosaminoglycan able to modulate cell behavior in the healthy and tumor context. Sulfated hyaluronan (sHA)...
9.
Vancza L, Karaszi K, Peterfia B, Turiak L, Dezso K, Sebestyen A, et al.
Front Oncol
. 2022 Feb;
12:819883.
PMID: 35186754
The extracellular matrix proteoglycan SPOCK1 is increasingly recognized as a contributor to the development and progression of cancers. Here, we study how SPOCK1, which is present in non-tumorous hepatocytes at...
10.
Reszegi A, Karaszi K, Toth G, Rada K, Vancza L, Turiak L, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33801718
Although syndecan-1 (SDC1) is known to be dysregulated in various cancer types, its implication in tumorigenesis is poorly understood. Its effect may be detrimental or protective depending on the type...